Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
7.23
-0.04 (-0.55%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Trinity Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -37.38 | -31.79 | -24.02 | -41.01 | 0.88 |
Depreciation & Amortization | 1.3 | 0.68 | 1.78 | 2.29 | 2.72 |
Other Amortization | 1.38 | 1.19 | - | 0.48 | 0.58 |
Loss (Gain) From Sale of Assets | - | - | - | 0 | -0 |
Asset Writedown & Restructuring Costs | 2.18 | 2.21 | 9.61 | 5.36 | 6.36 |
Stock-Based Compensation | 0.32 | 1.32 | 2.07 | 1.76 | 1.1 |
Other Operating Activities | 19.86 | 18.13 | 14.42 | 31.82 | 7.34 |
Change in Accounts Receivable | 4.92 | -2.37 | 1.05 | -0.97 | 6.24 |
Change in Inventory | 0.09 | -1.74 | -0.97 | -0.88 | -4.41 |
Change in Accounts Payable | 1.39 | 8.19 | -2.77 | 0.18 | -7.59 |
Operating Cash Flow | -5.93 | -4.19 | -11.56 | -0.92 | 13.24 |
Operating Cash Flow Growth | - | - | - | - | -44.27% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.09 | -0.41 | -0.8 | -1.1 | -1.81 |
Divestitures | - | - | 28.16 | - | - |
Sale (Purchase) of Intangibles | -6.14 | -9.66 | -1.9 | -4.88 | -6.88 |
Investment in Securities | - | - | -0.7 | - | - |
Other Investing Activities | - | -12.9 | - | - | - |
Investing Cash Flow | -6.22 | -22.97 | 24.76 | -5.98 | -8.69 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 1.76 |
Long-Term Debt Issued | 15 | 30.18 | 5 | 100.02 | - |
Total Debt Issued | 15 | 30.18 | 5 | 100.02 | 1.76 |
Long-Term Debt Repaid | -3.19 | -2.5 | -12.37 | -124.01 | -2.94 |
Lease Payments | -3.19 | -2.5 | -2.32 | -2.76 | -2.94 |
Net Debt Issued (Repaid) | 11.81 | 27.67 | -7.37 | -24 | -1.18 |
Issuance of Common Stock | 0.55 | 7.39 | - | 25.4 | - |
Other Financing Activities | -0.31 | -6.25 | -8.67 | -13.72 | -4.84 |
Financing Cash Flow | 12.05 | 28.81 | -16.04 | -12.32 | -6.02 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.07 | -0.18 | -0.04 | -0.11 | 0.06 |
Net Cash Flow | -0.03 | 1.48 | -2.89 | -19.33 | -1.42 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.02 | -4.6 | -12.36 | -2.02 | 11.43 |
Free Cash Flow Growth | - | - | - | - | -44.39% |
Free Cash Flow Margin | -13.74% | -7.47% | -21.75% | -3.23% | 14.08% |
Free Cash Flow Per Share | -9.72 | -7.68 | -48.44 | -8.99 | 82.00 |
Levered Free Cash Flow | -11.2 | -7.03 | -12.75 | -10.16 | -2.29 |
Unlevered Free Cash Flow | -3.19 | 0.41 | -6.4 | -2.95 | 2.14 |
Free Cash Flow After Leases | -9.2 | -7.1 | -14.68 | -4.78 | 8.49 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.31 | 6.25 | 7.62 | 7.92 | 4.01 |
Cash Income Tax Paid | 0.35 | -1.01 | -0.31 | 0.02 | -1.62 |
Change in Working Capital | 6.4 | 4.08 | -2.69 | -1.66 | -5.76 |